High-brightness Probes for Faster, More Robust COVID-19 Testing
High-brightness dyes developed by Michigan Tech researchers and StabiLux Biosciences, a Michigan-based health tech business founded by MTU faculty, offer the promise of greatly improving COVID-19 polymerase chain reaction testing methods. Their research was recently awarded a National Science Foundation Small Business Technology Transfer (NSF STTR) Phase I grant.
“The primary goal of technology transfer is to achieve societal benefit from discoveries made by researchers,” said Jim Baker, associate vice president for research administration. “This recent support from NSF to investigate applications of our technology to address COVID-19 is a great example of the potential public benefit achieved through the commercialization of Michigan Tech research outcomes.”
Read the full story on mtu.edu/news.